Skip to main content
. 2022 Jun 8;13:914372. doi: 10.3389/fgene.2022.914372

TABLE 1.

Characteristics and minor allele frequency (MAF) of the 70 single nucleotide polymorphisms (SNPs) detected in the Zimbabwean subjects. Each SNP had a MAF > 5%, and the predicted and reported functional changes of each cytochrome P450 (CYP) were described.

DNA strand Enzyme Identifier Allele MAF (%) Chromosome position Nucleotide change Amino acid change SIFT/GWAVA prediction Reported enzyme activity Variant consequence Region
EXP AFR ZIM EUR
1 CYP1A2 rs2069514 CYP1A2*1C 29.39 31.32 1.99* 74745879 G > A -/DEL Decreased (Nakajima et al., 1999) Upstream Gene
rs762551 CYP1A2*1F 53.51 56.2 57 67.99** 74749576 C > A -/DEL Increased (Lu et al., 2020) Intron I1
rs2069526 CYP1A2*1K 11.84 12.33 2.39* 74749000 T > G -/TOL Decreased (Al-Ahmad et al., 2017) Intron I1
NOVEL_74753482 Novel-1 12.72 74753482 G > A -/TOL Intron I6
NOVEL_74753485 Novel-2 86.84 74753485 G > C -/TOL Intron I6
NOVEL_74753512 Novel-3 13.16 74753512 C > T -/TOL Intron I6
NOVEL_74753515 Novel-4 7.02 74753515 G > A -/TOL Intron I6
NOVEL_74747828 Novel-5 8.33 74747828 C > T -/DEL Upstream Gene -
NOVEL_74747713 Novel-6 6.14 74747713 A > G -/DEL Upstream Gene -
NOVEL_74747716 Novel-7 7.46 74747716 C > T -/DEL Upstream Gene -
NOVEL_74747757 Novel-8 10.09 74747757 G > A -/DEL Upstream Gene -
rs1022705765 rs1022705765 10.53 0* 74753493 G > A -/TOL Intron I6
rs1450415112 rs1450415112 9.65 0* 74753511 A > G -/TOL Intron I6
rs951840747 rs951840747 10.09 0* 74753480 C > T -/TOL Intron I6
CYP2C9 rs2256871 CYP2C9*9 14.04 8.17 13 0.1* 94949217 A > G His251Arg DEL/DEL Normal (Matimba et al., 2009) Missense E5
NOVEL_94956743 Novel-9 7.46 - 94956743 T > C -/TOL Intron I5
NOVEL_94977838 Novel-10 6.14 - 94977838 C > T -/TOL Intron I6
rs2017319 rs2017319 13.60 12.03 10 0.2* 94988878 C > T Ala441 (3D) -/TOL Synonymous E9
rs75541073 rs75541073 16.23 19.14 0.1* 94948233 G > A -/TOL Intron I4
rs9332127 rs9332127 14.47 15.81 0.1* 94947714 G > C -/TOL Decreased (Wang et al., 2008; Gu et al., 2010) Intron I3
rs9332232 rs9332232 13.60 11.95 11 0.2* 94986275 T > C -/TOL Intron I8
rs9332241 rs9332241 7.02 3.78 5 0* 94989116 C > T -/TOL 3′ UTR E9
CYP2C19 rs4244285 CYP2C19*2 16.23 17.02 15 14.51 94781859 G > A Pro218 -/TOL Decreased (Dandara et al., 2001) Synonymous E5
rs12248560 CYP2C19*17 15.79 23.52 22.37 94761900 C > T -/DEL Increased (Sim et al., 2006; Gawrońska-Szklarz et al., 2012) Upstream Gene -
rs7902257 CYP2C19*27 13.60 8.25 0.1* 94761665 G > A -/- Uncertain (Helsby and Burns, 2012) Upstream Gene -
NOVEL_94779010 Novel-11 6.58 94779010 G > A -/TOL Intron I3
rs17879992 rs17879992 11.84 9.76 6.96 94775871 T > C -/TOL Intron I3
rs17884938 rs17884938 9.21 5.82 0.2* 94780934 T > A -/TOL Intron I4
rs17885567 rs17885567 5.70 5.60 10 0* 94850227 C > T -/TOL Intron I8
rs4917623 rs4917623 10.96 19.82 22** 50.8** 94849811 T > C -/TOL Intron I7
rs4986894 rs4986894 14.91 16.26 15 14.51 94762608 T > C -/DEL Upstream Gene -
rs76267522 rs76267522 5.26 2.34 0.1* 94780959 T > C -/TOL Intron I4
−1 CYP2D6 rs28371706 CYP2D6*17 16.67 21.80 20 0.2* 42129770 G > A Thr107Ile TOL/- Decreased (Masimirembwa et al., 1996) Missense E2
rs17002853 rs17002853 5.70 0* 0.1* 42128325 A > G Leu231Pro DEL/- Missense E5
rs28371702 rs28371702 75.88 77.08 29* 54.77* 42129950 A > C -/- Normal/Decreased (Zhang et al., 2021) Intron I1
CYP3A4 NOVEL_99761942 Novel-12 7.89 99761942 T > C -/TOL Intron I11
NOVEL_99764101 Novel-13 7.89 99764101 T > C -/TOL Intron I9
NOVEL_99766252 Novel-14 5.26 99766252 C > T -/TOL Intron I10
NOVEL_99764034 Novel-15 16.23 99764034 C > T -/TOL Intron I11
NOVEL_99764099 Novel-16 8.33 99764099 C > T -/TOL Intron I12
NOVEL_99762108 Novel-17 16.23 99762108 T > C Ile396Val TOL/DEL Missense E11
NOVEL_99762115 Novel-18 7.46 99762115 C > T Val393 -/TOL Synonymous E11
NOVEL_99762116 Novel-19 7.46 99762116 A > G Val393Ala TOL/DEL Missense E11
NOVEL_99784449 Novel-20 15.35 99784449 A > G -/DEL Upstream Gene
NOVEL_99784471 Novel-21 11.40 99784471 T > A -/DEL Upstream Gene
rs1006181087 rs1006181087 8.33 0* 99762118 C > T Val392 -/TOL Synonymous E11
rs12721622 rs12721622 9.65 4.39 0* 99768236 A > T -/TOL Intron I7
rs1479820461 rs1479820461 99.12 0* 0* 99783699 G > C -/DEL ntron I1
rs2687110 rs2687110 62.28 59.23 99.7** 99773128 A > T -/TOL - Intron I3
rs2687116 rs2687116 23.25 27.91 97.02** 99768320 C > A -/TOL Decreased (Panczyk, 2014) Intron I7
rs28988583 rs28988583 11.84 8.70 2.09* 99769086 A > G -/TOL Intron I6
rs3735451 rs3735451 82.02 81.39 9.94* 99758352 T > C -/TOL Intron I13
rs746971934 rs746971934 8.33 0* 99762120 C > A Val392Leu DEL/DEL Missense E11
rs778270963 rs778270963 15.79 0* 99762101 C > A Ser398Ile TOL/- Missense E11
rs915268104 rs915268104 6.58 0* 99783718 C > T -/DEL Intron I1
CYP3A5 rs776746 CYP3A5*3 15.79 18 77.6** 94.33** 99672916 T > C -/- Inactive (Kuehl et al., 2001; Sanghavi et al., 2017) Intron I3
rs10264272 CYP3A5*6 15.35 15.43 22 0.3* 99665212 C > T Lys208 -/DEL Inactive (Kuehl et al., 2001; Sanghavi et al., 2017) Synonymous E7
NOVEL_99672254 Novel-22 15.79 99672254 G > A -/TOL Intron I4
NOVEL_99672211 Novel-23 97.81 99672211 G > C -/TOL Intron I4
NOVEL_99672251 Novel-24 5.26 99672251 C > T -/TOL Intron I4
NOVEL_99672285 Novel-25 15.35 99672285 C > T -/TOL Intron I4
NOVEL_99666556 Novel-26 6.14 99666556 A > G -/DEL Intron I6
rs1039108105 rs1039108105 9.21 0* 0* 99656082 G > C -/TOL Intron I10
rs1458424958 rs1458424958 5.26 0* 0* 99673203 A > G -/TOL Intron I3
rs1462057054 rs1462057054 16.67 0* 0* 99672249 A > G -/TOL Intron I4
rs2040992 rs2040992 100 99.92 98.61 99664949 G > A -/DEL Intron I7
rs41303322 rs41303322 10.53 11.88 0* 99664999 T > C -/TOL Intron I7
rs4646453 rs4646453 9.21 8.77 1.89* 99662739 C > A -/TOL Intron I13
rs6976017 rs6976017 20.18 13.99 3.08* 99652376 G > A -/TOL Intron I11
rs8175345 rs8175345 9.65 8.09 0* 99672695 G > A -/DEL Intron I3

* and ** represents a significantly higher or lower difference in the minor allele frequency (MAF) in this Zimbabwean (ZIM) study population compared to the reported MAF in the African (AFR)/European (EUR) population in the 1,000 Genomes Project using Pearson’s chi-square tests.

SIFT, sorting Intolerant From Tolerant; GWAVA, Genome-Wide Annotation of Variants; DEL, Deleterious effect on protein function; TOL, Tolerated effect on protein function. Region described by: Exon (E) and Intron (I). CYP, Cytochrome P450 enzyme.